Enzo Biochem Inc financial data

Symbol
ENZ on NYSE
Industry
Services-Medical Laboratories
Location
60 Executive Blvd, Farmingdale, New York
State of incorporation
New York
Fiscal year end
July 31
Latest financial report
10-Q - Q1 2024 - Jun 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 296 % +112%
Quick Ratio 26.5 % -47.5%
Debt-to-equity 43.8 % -58.1%
Return On Equity 61.2 %
Return On Assets 42.5 %
Operating Margin -50.7 % -159%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51.5M shares +3.48%
Common Stock, Shares, Outstanding 51.2M shares +3.14%
Entity Public Float 56.4M USD -57.2%
Common Stock, Value, Issued 511K USD +3.02%
Weighted Average Number of Shares Outstanding, Basic 51.2K shares +3.71%
Weighted Average Number of Shares Outstanding, Diluted 51.2K shares +3.71%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 33.3M USD +7.17%
Cost of Revenue 17.2M USD -4.18%
Research and Development Expense 3.23M USD +31.9%
Costs and Expenses 29.4M USD -4.47%
Operating Income (Loss) -16.9M USD +38.9%
Nonoperating Income (Expense) -88K USD -119%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -17.5M USD +73%
Net Income (Loss) Attributable to Parent 44.7M USD +80.1%
Earnings Per Share, Basic 0.92 USD/shares +80.6%
Earnings Per Share, Diluted 0.92 USD/shares +80.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 57.2M USD +2072%
Accounts Receivable, after Allowance for Credit Loss, Current 3.94M USD -59.2%
Inventory, Net 7.32M USD -52.1%
Assets, Current 75.7M USD +137%
Property, Plant and Equipment, Net 12.6M USD -27.8%
Operating Lease, Right-of-Use Asset 2.96M USD -78%
Intangible Assets, Net (Excluding Goodwill) 29K USD -90.8%
Goodwill 7.45M USD 0%
Other Assets, Noncurrent 591K USD -64.1%
Assets 93.5M USD +29.7%
Employee-related Liabilities, Current 6.45M USD +50.8%
Accrued Liabilities, Current 5.38M USD -69.3%
Liabilities, Current 21.7M USD -48.6%
Operating Lease, Liability, Noncurrent 2.6M USD -75.8%
Other Liabilities, Noncurrent 18K USD -81.3%
Liabilities 24.4M USD -54%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.5M USD +15.8%
Retained Earnings (Accumulated Deficit) -281M USD +13.7%
Stockholders' Equity Attributable to Parent 69M USD +265%
Liabilities and Equity 93.5M USD +29.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.4M USD -53.8%
Net Cash Provided by (Used in) Financing Activities -518K USD -445%
Net Cash Provided by (Used in) Investing Activities -254K USD +61%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 51.2M shares +3.14%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.2M USD -49.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 57.2M USD +1474%
Interest Paid, Excluding Capitalized Interest, Operating Activities 53K USD -5.36%
Deferred Tax Assets, Valuation Allowance 26.7M USD -22.9%
Deferred Tax Assets, Gross 30M USD -25.3%
Operating Lease, Liability 3.39M USD -8.42%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 45.1M USD +83.5%
Lessee, Operating Lease, Liability, to be Paid 3.75M USD -76.5%
Property, Plant and Equipment, Gross 28.3M USD +10.1%
Operating Lease, Liability, Current 799K USD -78.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 886K USD -79.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 896K USD -21.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 355K USD -76.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 881K USD -76.9%
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 808K USD -76.5%
Additional Paid in Capital 347M USD +1.47%
Amortization of Intangible Assets 22K USD -75.6%
Depreciation, Depletion and Amortization 270K USD -65.4%
Deferred Tax Assets, Net of Valuation Allowance 34.6M USD +15.9%
Share-based Payment Arrangement, Expense 1.72M USD +10.5%
Interest Expense -1.38M USD -2117%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%